Understanding these differences is key for patients
10 Majority of patients had CVD and were receiving SOC 6,7,a 97% were receiving glucose-lowering medications 6 Patient characteristics at baseline (N=9650) 6,7 Select history of CVD at baseline (N=9650) 6 Select history of medication use at baseline (N=9650) 6,10 a Standard care consisted of glucose-lowering and cardiovascular riskreducing therapies administered in accordance with local guidelines
The typical price range charged to insurers for either is around $900-$1,300 per month, and one insurance plan will bring that cost down more or less than another, even within the same company
These medications include insulin injections and sulfonylurea drugs, such as Glucotrol (glipizide), DiaBeta (glyburide), Amaryl (glimepiride), and others
Tracking is available through email and the patient portal, though the in-portal tracking froze on my order and never updated